Pathfinder Cell Therapy Inc PFND
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 667.16M
- Market Cap
- $667.16
- Volume/Avg
- 1,000 / 5,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (PCs) themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1
Valuation
|
Metric
|
PFND
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PFND
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −2.54 |
Quick Ratio
No chart available
Profitability
|
Metric
|
PFND
|
|---|---|
Return on Assets (Normalized) | −1,542.86% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|&@&^cTr | LOCK|qkJl | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|x<JL@>B | LOCK|#g$^q | $83B | |||
| Moderna Inc
MRNA
| LOCK|H&T!$# | LOCK|?v | $80B | |||
| argenx SE ADR
ARGX
| LOCK|!%gX>h | LOCK|Z^ | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>pMyh?J | LOCK|^v | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|#nptTL | LOCK|Q&Gs | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|dlsk&C<& | LOCK|qsQB@ | $28B | |||
| Incyte Corp
INCY
| LOCK|@b&>cy$ | LOCK|s@$ | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|PGwKhlx | LOCK|sj! | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|q#zz?M$ | LOCK|BL$ | $14B |
United States